CIENCIAS FARMACÉUTICAS
Department
Instituto de Investigación Sanitaria del Hospital Universitario La Paz
Madrid, EspañaPublications in collaboration with researchers from Instituto de Investigación Sanitaria del Hospital Universitario La Paz (6)
2024
-
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients
Inflammatory Bowel Diseases, Vol. 30, Núm. 2, pp. 167-182
-
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis
Gastroenterologia y Hepatologia, Vol. 47, Núm. 5, pp. 522-552
2023
-
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91
2022
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Prognostic markers of inflammation in endometrioid and clear cell ovarian cancer
International Journal of Gynecological Cancer, Vol. 32, Núm. 8, pp. 1009-1016
2020
-
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease
United European Gastroenterology Journal, Vol. 8, Núm. 9, pp. 1056-1066